United States Biotechnology & Medical Research

Pathfinder Cell Therapy Inc (PFND)

Track

Ticker: PFND Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
PINE ELI Vice President, CSO Officer
Transaction date
Purchase
Price
51.78
Quantity 7,970 -15.3%
Value US$2,508,179
FRANKLIN RICHARD L Chairman of the Board Executive Director
Transaction date
Purchase
Price
482.35
Quantity 57,853 -48.2%
Value US$3,026,032
FRANKLIN RICHARD L Chairman of the Board Executive Director
Transaction date
Purchase
Price
313.92
Quantity 82,164 +1.0%
Value US$1,758,337
HICKEY ROBERT P President,CEO,CFO Executive Director
Transaction date
Purchase
Price
0.72
Quantity 10,000 +4.0%
Value US$7,200
FRANKEL BARRY R Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 1,700 +48.6%
Value US$1,700
FRANKEL BARRY R Non-Executive Director
Transaction date
Purchase
Price
0.92
Quantity 3,500 +inf%
Value US$3,220
CELANO EDWARD A Non-Executive Director
Transaction date
Planned sale
Price
1.02
Quantity 1,200 -1.9%
Value US$1,224
CELANO EDWARD A Non-Executive Director
Transaction date
Planned sale
Price
1.03
Quantity 7,500 -10.7%
Value US$7,725
CELANO EDWARD A Non-Executive Director
Transaction date
Planned sale
Price
0.76
Quantity 522 -0.8%
Value US$397
FRANKLIN RICHARD L Chairman of the Board Executive Director
Transaction date
Purchase
Price
0.34
Quantity 113,424 +inf%
Value US$38,564
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-12-11 2008-12-09 B Purchase PINE ELI

Vice President, CSO

Officer
7,970 -15.3%
51.78
US$2,508,179 		7,970 -15.3% 51.78 US$2,508,179
2008-06-11 2008-06-06 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
57,853 -48.2%
482.35
US$3,026,032 		57,853 -48.2% 482.35 US$3,026,032
2007-10-11 2007-10-10 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
82,164 +1.0%
313.92
US$1,758,337 		82,164 +1.0% 313.92 US$1,758,337
2007-09-26 2007-09-26 B Purchase HICKEY ROBERT P

President,CEO,CFO

Executive Director
10,000 +4.0%
0.72
US$7,200 		10,000 +4.0% 0.72 US$7,200
2007-06-04 2007-06-04 B Purchase FRANKEL BARRY R Non-Executive Director
1,700 +48.6%
1.00
US$1,700 		1,700 +48.6% 1.00 US$1,700
2007-06-04 2007-05-31 B Purchase FRANKEL BARRY R Non-Executive Director
3,500 +inf%
0.92
US$3,220 		3,500 +inf% 0.92 US$3,220
2007-03-29 2007-03-28 PlS Planned sale CELANO EDWARD A Non-Executive Director
1,200 -1.9%
1.02
US$1,224 		1,200 -1.9% 1.02 US$1,224
2007-03-29 2007-03-27 PlS Planned sale CELANO EDWARD A Non-Executive Director
7,500 -10.7%
1.03
US$7,725 		7,500 -10.7% 1.03 US$7,725
2007-02-23 2007-02-21 PlS Planned sale CELANO EDWARD A Non-Executive Director
522 -0.8%
0.76
US$397 		522 -0.8% 0.76 US$397
2006-10-10 2006-10-06 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
113,424 +inf%
0.34
US$38,564 		113,424 +inf% 0.34 US$38,564
Explore more

More insider trading research around Pathfinder Cell Therapy Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America